![Christian S. Eversull](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Christian S. Eversull
Direktor/Vorstandsmitglied bei MateraCor, Inc.
Aktive Positionen von Christian S. Eversull
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
MateraCor, Inc.
![]() MateraCor, Inc. Medical SpecialtiesHealth Technology Part of BioVentrix, Inc., MateraCor, Inc. is a southern-based biotech start-up that develops novel approaches to prevent progression and reverse heart failure. The company is based in Aliso Viejo, CA. The company's lead product, Trans-Catheter Myocardial Restoration (TCMR), is an investigational device that consists of an implantable hydrogel and a minimally invasive endocardial delivery system to treat ischemic or non-ischemic heart failure with reduced ejection faction (HFREF). The CEO of the company is Frank A. Ahmann. MateraCor was acquired by BioVentrix, Inc. on January 27, 2022. | Direktor/Vorstandsmitglied | - | - |
Karriereverlauf von Christian S. Eversull
Ehemalige bekannte Positionen von Christian S. Eversull
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Bacchus Vascular, Inc.
![]() Bacchus Vascular, Inc. Medical SpecialtiesHealth Technology Bacchus Vascular, Inc. manufactures and sells medical devices. It provides treatments for peripheral vascular diseases. The company was founded by Nellix Michael and Thomas J. Fogarthy in 1999 and is headquartered in Santa Clara, CA. | Corporate Officer/Principal | - | - |
Acumen Medical, Inc.
![]() Acumen Medical, Inc. Medical SpecialtiesHealth Technology Acumen Medical, Inc. developed therapeutic devices. The company was founded in 2002 by Nicholas J. Mourlas, Christian S. Eversull and Stephen A. Leeflang and was headquartered in Sunnyvale, CA. | Direktor/Vorstandsmitglied | 01.01.2002 | 03.11.2009 |
Technik-/Wissenschafts-/F&E-Leiter | 01.01.2002 | - | |
Gründer | 02.11.2009 | - |
Ausbildung von Christian S. Eversull
Stanford University | Graduate Degree |
Statistik
International
Vereinigte Staaten | 5 |
Operativ
Director/Board Member | 2 |
Chief Tech/Sci/R&D Officer | 1 |
Founder | 1 |
Sektoral
Health Technology | 4 |
Consumer Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Private Unternehmen | 3 |
---|---|
Acumen Medical, Inc.
![]() Acumen Medical, Inc. Medical SpecialtiesHealth Technology Acumen Medical, Inc. developed therapeutic devices. The company was founded in 2002 by Nicholas J. Mourlas, Christian S. Eversull and Stephen A. Leeflang and was headquartered in Sunnyvale, CA. | Health Technology |
Bacchus Vascular, Inc.
![]() Bacchus Vascular, Inc. Medical SpecialtiesHealth Technology Bacchus Vascular, Inc. manufactures and sells medical devices. It provides treatments for peripheral vascular diseases. The company was founded by Nellix Michael and Thomas J. Fogarthy in 1999 and is headquartered in Santa Clara, CA. | Health Technology |
MateraCor, Inc.
![]() MateraCor, Inc. Medical SpecialtiesHealth Technology Part of BioVentrix, Inc., MateraCor, Inc. is a southern-based biotech start-up that develops novel approaches to prevent progression and reverse heart failure. The company is based in Aliso Viejo, CA. The company's lead product, Trans-Catheter Myocardial Restoration (TCMR), is an investigational device that consists of an implantable hydrogel and a minimally invasive endocardial delivery system to treat ischemic or non-ischemic heart failure with reduced ejection faction (HFREF). The CEO of the company is Frank A. Ahmann. MateraCor was acquired by BioVentrix, Inc. on January 27, 2022. | Health Technology |
- Börse
- Insiders
- Christian S. Eversull
- Erfahrung